SFM
TBIO

Sphera Funds Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Sphera Funds Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-309,400
Closed -$2.32M – 130
2018
Q4 		$2.32M Buy
309,400
+32,761
+12% +$240K 0.26% 70
2018
Q3 		$2.77M Buy
276,639
+146,639
+113% +$1.71M 0.32% 77
2018
Q2 		$1.65M Buy
+130,000
New +$1.57M 0.23% 85

Other funds holding TBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Sphera Funds Management's TBIO Position: Q1 2019 in Review

Sphera Funds Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2019, closing a stake of 309,400 shares — an estimated $2.32M sold.

Sphera Funds Management first reported a position in TBIO in Q2 2018 and held it in 3 quarters. The position peaked at $2.77M in Q3 2018. 52 funds tracked by Wall St. Rank hold TBIO as of Q1 2019.

  • Sphera Funds Management reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Sphera Funds Management sold 309,400 Translate Bio, Inc. Common Stock shares in Q1 2019, an estimated $2.32M.
  • Sphera Funds Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • Sphera Funds Management's Translate Bio, Inc. Common Stock position peaked at $2.77M in Q3 2018.
  • 52 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.